Scarica l'app Stockscreener
2.79
2.95%
0.08
Dopo l'orario di chiusura:
2.60
-0.19
-6.81%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$2.71
Aprire:
$2.68
Volume 24 ore:
435.20K
Relative Volume:
2.06
Capitalizzazione di mercato:
$179.05M
Reddito:
-
Utile/perdita netta:
$-40.33M
Rapporto P/E:
-1.5587
EPS:
-1.79
Flusso di cassa netto:
$-39.53M
1 W Prestazione:
+1.45%
1M Prestazione:
-7.00%
6M Prestazione:
-32.28%
1 anno Prestazione:
+11.16%
Intervallo 1D:
$2.64
$2.825
Intervallo di 1 settimana:
$2.60
$2.912
Portata 52W:
$2.30
$5.54
Eledon Pharmaceuticals Inc Stock (ELDN) Company Profile
Nome
Eledon Pharmaceuticals Inc
Settore
Industria
Telefono
949-238-8090
Indirizzo
19800 MACARTHUR BLVD., IRVINE
Confronta ELDN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ELDN
Eledon Pharmaceuticals Inc
|
2.79 | 179.05M | 0 | -40.33M | -39.53M | -1.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.16 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
534.91 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.06 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
542.47 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.16 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Eledon Pharmaceuticals Inc Stock (ELDN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-28 | Iniziato | Guggenheim | Buy |
| 2022-05-13 | Ripresa | Cantor Fitzgerald | Overweight |
| 2021-03-23 | Iniziato | Cantor Fitzgerald | Overweight |
Eledon Pharmaceuticals Inc Borsa (ELDN) Ultime notizie
ELDN: HC Wainwright & Co. Sets New Price Target for Eledon Pharm - GuruFocus
H.C. Wainwright assumes coverage on Eledon stock with buy rating By Investing.com - Investing.com UK
H.C. Wainwright Reaffirms Buy Rating for Eledon Pharmaceuticals - GuruFocus
Bank of America Corp DE Increases Stock Holdings in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
Eledon Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks
Millennium Management LLC Invests $490,000 in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
Eledon Pharmaceuticals (NASDAQ:ELDN) Rating Lowered to Sell at Wall Street Zen - Defense World
Short Interest in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) Declines By 12.3% - Defense World
Northern Trust Corp Boosts Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
Jane Street Group LLC Makes New $504,000 Investment in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
What Makes Eledon Pharmaceuticals (ELDN) a New Buy Stock - MSN
Eledon Pharmaceuticals Reports Q1 2025 Progress and Financials - TipRanks
What is Noble Financial’s Estimate for ELDN Q2 Earnings? - Defense World
Cubist Systematic Strategies LLC Takes $101,000 Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
Balyasny Asset Management L.P. Invests $134,000 in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
Q2 EPS Estimate for Eledon Pharmaceuticals Lifted by Analyst - Defense World
FY2025 EPS Estimates for ELDN Boosted by Cantor Fitzgerald - Defense World
Dimensional Fund Advisors LP Sells 11,190 Shares of Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
Cantor Fitzgerald maintains Overweight on Eledon Pharmaceuticals stock By Investing.com - Investing.com UK
Tower Research Capital LLC TRC Purchases 6,412 Shares of Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
Eledon (ELDN) Advances Tegoprubart for Organ Transplant Therapy - GuruFocus
Eledon (ELDN) Advances Tegoprubart for Organ Transplant Therapy | ELDN Stock News - GuruFocus
Eledon Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results - The Manila Times
Barclays PLC Makes New $288,000 Investment in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
Eledon Pharmaceuticals (ELDN) Expected to Announce Quarterly Earnings on Thursday - Defense World
Undercovered Dozen: Gevo, Eledon, Dorian, Iridium + - Seeking Alpha
Eledon Pharmaceuticals Inc expected to post a loss of 30 cents a shareEarnings Preview - TradingView
Eledon: A Company With Good Early Data In Kidney Transplant Rejection And A Full Balance Sheet - Seeking Alpha
Analysts Offer Insights on Healthcare Companies: GeoVax Labs (GOVX) and Baxter International (BAX) - The Globe and Mail
Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) has caught the attention of institutional investors who hold a sizeable 46% stake - Yahoo Finance
Geode Capital Management LLC Buys 285,043 Shares of Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
Press Release Distribution & PR Platform - ACCESS Newswire
Eledon Pharmaceuticals appoints Deloitte as new auditor By Investing.com - Investing.com Nigeria
Midday Stock Roundup: Evolus, ICU Medical down - Orange County Business Journal
Eledon Pharmaceuticals appoints Deloitte as new auditor - Investing.com
Charles Schwab Investment Management Inc. Purchases 15,000 Shares of Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
Virtu Financial LLC Takes $82,000 Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) - Defense World
Is Eledon Pharmaceuticals (ELDN) The Hot Biotech Stock Under $5? - Insider Monkey
Equities Analysts Set Expectations for ELDN FY2025 Earnings - Defense World
Research Analysts Set Expectations for ELDN FY2025 Earnings - Defense World
What is Leerink Partnrs’ Forecast for ELDN Q1 Earnings? - Defense World
Eledon Pharmaceuticals Reports 2024 Financial Results and Clinical Advances - MSN
We're Hopeful That Eledon Pharmaceuticals (NASDAQ:ELDN) Will Use Its Cash Wisely - Yahoo
10 Hot Biotech Stocks Under $5 - Insider Monkey
Eledon Pharmaceuticals, Inc. SEC 10-K Report - TradingView
Eledon Pharmaceuticals Inc. (ELDN) reports earnings - Quartz
Eledon Pharmaceuticals Inc Azioni (ELDN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.39%
0.42%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):